Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SYNAPTICS IncSYNA · Entity 4089 | See Remarks | November 17, 2023 | November 22, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SYNAPTICS Inc
Report date November 17, 2023 · Filed November 22, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,015 |
Reported balance
After 2023-11-17 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-11-17 · Grant · Acquired 698 · Balance 17,015 F1: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021. F2: Includes 27 shares acquired under the Issuer's employee stock purchase plan on September 15, 2023. |
| Common StockSEC Table I · non-derivative | Direct | 16,067 |
Reported balance
After 2023-11-17 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2023-11-17 · Tax withholding · Disposed 948 · Balance 16,067 F3: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units. |
| Common StockSEC Table I · non-derivative | Direct | 15,183 |
Reported balance
After 2023-11-20 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2023-11-20 · Sale · Disposed 884 · Balance 15,183 F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.7816 to $105.8350, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares released in connection with the vesting of performance stock units granted on August 17, 2021.
F2: Includes 27 shares acquired under the Issuer's employee stock purchase plan on September 15, 2023.
F3: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance stock units and restricted stock units.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.7816 to $105.8350, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $85.69 | $0.00 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · derivative · entry 21 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2022-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the April 24, 2015 date of grant, until fully vested on April 24, 2018. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $76.81 | $0.00 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · derivative · entry 20 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2022-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the January 30, 2015 date of grant, until fully vested on January 30, 2018. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,725 | $0.00 Strike: $89.29 | $0.00 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · derivative · entry 19 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,725 shares Expires 2022-10-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the October 23, 2015 date of grant, until fully vested on October 23, 2018. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $79.38 | $0.00 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · derivative · entry 18 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2022-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the July 31, 2015 date of grant, until fully vested on July 31, 2018. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 4,211 | $121.47 | $511,495.85 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · nonDerivative · entry 10 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,860 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.928 to $121.740, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,674 | $120.43 | $201,605.85 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · nonDerivative · entry 9 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,071 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.92 to $120.79, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 8,190 | $118.66 | $971,826.22 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · nonDerivative · entry 8 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,745 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118 to $118.94, inclusive. The reporting person undertakes to provide to Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 3,100 | $117.47 | $364,154.21 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · nonDerivative · entry 7 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,935 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.92 to $117.79, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 2,725 | $71.55 | $194,973.75 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · nonDerivative · entry 6 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 2,725 | $73.31 | $199,769.75 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · nonDerivative · entry 5 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 3,000 | $85.69 | $257,070.00 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · nonDerivative · entry 4 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 3,000 | $76.81 | $230,430.00 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · nonDerivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 2,725 | $89.29 | $243,315.25 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 22:52 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 3,000 | $79.38 | $238,140.00 |
DisclosureSEC source: 0001209191-21-009358 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,860 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:18 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 300 | $84.50 | $25,348.50 |
DisclosureSEC source: 0001209191-20-057779 · doc4.xml · nonDerivative · entry 4 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,860 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.49 to $84.50, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:18 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 4,383 | $83.38 | $365,472.95 |
DisclosureSEC source: 0001209191-20-057779 · doc4.xml · nonDerivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,160 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.00 to $83.96, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:18 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 2,097 | $82.41 | $172,805.17 |
DisclosureSEC source: 0001209191-20-057779 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,543 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.00 to $82.95, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 11, 2020 00:18 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 3,695 | $81.60 | $301,510.89 |
DisclosureSEC source: 0001209191-20-057779 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,640 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.00 to $81.99, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:39 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 5,236 | $76.67 | $401,444.12 |
DisclosureSEC source: 0001209191-20-056717 · doc4.xml · nonDerivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,335 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:39 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 6,266 | $76.67 | $480,414.22 |
DisclosureSEC source: 0001209191-20-056717 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,571 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units. Read SEC document |
| October 31, 2020 Filed Nov 3, 2020 22:39 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 11,971 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056717 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,837 F1 · shares: Reflects shares released in connection with the vesting of performance-based market stock units granted on October 31, 2017, November 13, 2018 and October 31, 2019. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 21:16 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,403 | $83.41 | $117,022.55 |
DisclosureSEC source: 0001209191-20-054680 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,866 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.35 to $83.49, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 21:16 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 7,811 | $82.92 | $647,717.80 |
DisclosureSEC source: 0001209191-20-054680 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,269 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.35 to $83.34, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 07, 2020 Filed Oct 9, 2020 21:17 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 10,121 | $81.66 | $826,480.86 |
DisclosureSEC source: 0001209191-20-054523 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,080 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units. Read SEC document |
| October 07, 2020 Filed Oct 9, 2020 21:17 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 19,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-054523 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,201 F1 · shares: Reflects shares released in connection with the vesting of performance-based market stock units granted on October 31, 2017, November 13, 2018, and October 31, 2019. F2 · balance_after: Includes 40 shares acquired under the Issuer's employee stock purchase plan on September 15, 2020. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 21:19 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 6,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047557 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,826 F1 · shares: One-third of the total number of deferred stock units shall vest on each anniversary following the vesting commencement date of August 17, 2020, until fully vested on August 17, 2023. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:24 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 298 | $0.00 Strike: $45.32 | $0.00 |
DisclosureSEC source: 0001209191-20-046414 · doc4.xml · derivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 298 shares Expires 2024-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 33% of the total number of shares subject to the option vested and became exercisable on August 4, 2018 following the vesting commencement date of August 4, 2017. The remaining 2/3rds vested quarterly until fully vested on August 4, 2020. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:24 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 298 | $88.99 | $26,519.02 |
DisclosureSEC source: 0001209191-20-046414 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,880 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 21:24 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 298 | $45.32 | $13,505.36 |
DisclosureSEC source: 0001209191-20-046414 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 21:22 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $62.11 | $0.00 |
DisclosureSEC source: 0001209191-20-043507 · doc4.xml · derivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2021-10-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable on each quarter following the October 24, 2014 date of grant, until fully vested on October 24, 2017. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 21:22 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 3,000 | $80.00 | $240,000.00 |
DisclosureSEC source: 0001209191-20-043507 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,880 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 21:22 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 3,000 | $62.11 | $186,315.00 |
DisclosureSEC source: 0001209191-20-043507 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 22:24 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $59.34 | $0.00 |
DisclosureSEC source: 0001209191-20-035097 · doc4.xml · derivative · entry 4 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2021-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/12th of the total number of shares subject to the option vested and became exercisable each quarter following the May 14, 2014 date of grant until fully vested on May 14, 2017. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 22:24 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 4,000 | $70.01 | $280,040.00 |
DisclosureSEC source: 0001209191-20-035097 · doc4.xml · nonDerivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,880 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 22:24 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 1,000 | $70.00 | $70,000.00 |
DisclosureSEC source: 0001209191-20-035097 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,880 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 22:24 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 5,000 | $59.34 | $296,700.00 |
DisclosureSEC source: 0001209191-20-035097 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:55 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,277 | $0.00 Strike: $45.32 | $0.00 |
DisclosureSEC source: 0001209191-20-028982 · doc4.xml · derivative · entry 5 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298 Underlying: Common Stock · 3,277 shares Expires 2024-08-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 33% of the total number of shares subject to the option vested and became exercisable one year following the vesting commencement date of August 4, 2017, with the remaining two-thirds vesting quarterly until fully vested on August 4, 2020. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:55 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 61 | $67.14 | $4,095.54 |
DisclosureSEC source: 0001209191-20-028982 · doc4.xml · nonDerivative · entry 4 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,880 F2 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:55 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 2,343 | $66.29 | $155,324.26 |
DisclosureSEC source: 0001209191-20-028982 · doc4.xml · nonDerivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,941 F2 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.99 to $66.86, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:55 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 4,251 | $65.59 | $278,827.77 |
DisclosureSEC source: 0001209191-20-028982 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,284 F2 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 10, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.99 to $65.94, inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2020 Filed May 13, 2020 22:55 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 3,277 | $45.32 | $148,513.64 |
DisclosureSEC source: 0001209191-20-028982 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 65 shares acquired under the Issuer's employee stock purchase plan in November 2019 and 20 shares acquired under the Issuer's employee stock purchase plan in March 2020. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 23:45 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 279 | $0.00 Strike: $46.08 | $0.00 |
DisclosureSEC source: 0001209191-19-056471 · doc4.xml · derivative · entry 4 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 279 shares Expires 2020-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the total number of shares subject to the option vested and became exercisable on November 4, 2014, and 1/36th of the total number of shares subject to the option vested and became exercisable on the 4th day of each month thereafter until fully vested on November 4, 2016. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 23:45 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 6,988 | $57.83 | $404,116.04 |
DisclosureSEC source: 0001209191-19-056471 · doc4.xml · nonDerivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,173 F1 · kind: The shares sold pursuant to a 10b5-1 Trading Plan dated February 20, 2019. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 23:45 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 279 | $58.00 | $16,182.00 |
DisclosureSEC source: 0001209191-19-056471 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,161 F1 · kind: The shares sold pursuant to a 10b5-1 Trading Plan dated February 20, 2019. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 23:45 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Exercise / conversionCommon Stock | 279 | $46.08 | $12,856.32 |
DisclosureSEC source: 0001209191-19-056471 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2019 Filed Nov 5, 2019 15:17 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 11,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055090 · doc4.xml · nonDerivative · entry 4 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,161 F4 · shares: One-third of the total number of deferred stock units shall vest on each anniversary following the vesting commencement date of October 31, 2019, until fully vested on October 31, 2022. Read SEC document |
| October 31, 2019 Filed Nov 5, 2019 15:17 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 4,305 | $42.11 | $181,283.55 |
DisclosureSEC source: 0001209191-19-055090 · doc4.xml · nonDerivative · entry 3 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,119 F3 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of deferred stock units. Read SEC document |
| October 31, 2019 Filed Nov 5, 2019 15:17 UTC | SYNAPTICS Inc SYNA · Entity 4089 | Tax withholdingCommon Stock | 3,455 | $42.11 | $145,490.05 |
DisclosureSEC source: 0001209191-19-055090 · doc4.xml · nonDerivative · entry 2 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,424 F2 · shares: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units. Read SEC document |
| October 31, 2019 Filed Nov 5, 2019 15:17 UTC | SYNAPTICS Inc SYNA · Entity 4089 | GrantCommon Stock | 6,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055090 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,879 F1 · shares: Reflects shares released on October 31, 2019 in connection with the vesting of performance-based market stock units granted on October 31, 2017 and November 13, 2018. Read SEC document |
| October 07, 2019 Filed Oct 8, 2019 23:32 UTC | SYNAPTICS Inc SYNA · Entity 4089 | SaleCommon Stock | 2,926 | $41.00 | $119,966.00 |
DisclosureSEC source: 0001209191-19-052805 · doc4.xml · nonDerivative · entry 1 McFarland John · CIK 0001486742 · SVP, General Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,275 F1 · kind: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 20, 2019. F2 · balance_after: Includes 54 shares acquired under the Issuer's employee stock purchase plan in November 2018 and 64 shares acquired under the Issuer's employee stock purchase plan in May 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.